Author Question: You are caring for a patient with chronic bronchitis. The patient has an SpO2 of 90. You should: ... (Read 88 times)

DelorasTo

  • Hero Member
  • *****
  • Posts: 548
You are caring for a patient with chronic bronchitis. The patient has an SpO2 of 90. You should:
 
  A) administer supplemental oxygen at high flow 15 lpm via NRB.
  B) administer supplemental oxygen at high flow, via CPAP.
  C) administer supplemental oxygen at low flow, via nasal cannula.
  D) do nothing, as this is an expected reading.

Question 2

You have been dispatched to transfer a patient with schizophrenia from a hospital emergency department to a behavioral health unit at another hospital. While en route, your partner states that he cannot remember what schizophrenia is. You should tell him that schizophrenia is a behavioral disorder commonly characterized by:
 
  A) multiple personalities.
  B) the need to be around others.
  C) delusions and hallucinations.
  D) feelings of worthlessness.


kristenb95

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

C

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library